The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Share News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 17th Jan 2014 10:05

Aberdeen Asset Management: JP Morgan cuts target price from 544p to 529p, while its overweight rating remains unchanged. Canaccord Genuity reduces target price from 586p to 540p and reiterates a buy recommendation. UBS lowers target price from 540p to 520p and keeps a buy recommendation.Ashtead Group: JP Morgan increases target price from 817p to 913p and stays with its overweight rating.Associated British Foods: Societe Generale raises target price from 2260p to 2600p and reiterates a hold recommendation.AstraZeneca: UBS increases target price from 400p to 4150p and keeps its buy recommendation.Aviva: Goldman Sachs takes target price from 230p to 260p and reiterates a neutral rating.Bovis Homes Group: HSBC increases target price from 1065p to 1125p keeping an overweight rating.Brain Juicer: Canaccord Genuity takes target price from 298p to 350p retaining its buy recommendation.Croda International: UBS moves target price from 2500p to 2525p maintaining its neutral rating.CSR: Liberum Capital raises target price from 580p to 700p, while downgrading to hold.Diageo: JP Morgan reduces target price from 2050p to 1970p downgrading to neutral.Dixons Retail: Investec lowers target price from 62p to 56p keeping its buy recommendation. UBS shapes target price from 60p to 58p leaving its buy recommendation unchanged.Domino Printing: UBS increases target price from 720p to 840p reiterating a neutral rating.Experian: Canaccord Genuity reduces target price from 905p to 858p retaining its sell recommendation.F&C Asset Management: Canaccord Genuity cuts target price from 130p to 110p and downgrades from buy to hold.First Group: Panmure Gordon ups target price from 120p to 140p and reiterates its hold recommendation.Halfords Group: Citi shifts target price from 545p to 550p and stays with its buy recommendation.Harvey Nash: Panmure Gordon moves target price from 126p to 135p retaining a buy recommendation.Hays: Liberum Capital starts with a target price of 170p and a buy recommendation.Home Retail: Deutsche Bank shifts target price from 225p to 230p maintaining a buy recommendation. Societe Generale ups target price from 158p to 175p, while still recommending selling. Citi moves target price from 195p to 205p and retains a neutral rating. HSBC ups target price from 220p to 250p and reiterates its overweight rating. Nomura moves target price from 215p to 230p and maintains a buy recommendation.Inchcape: Panmure Gordon raises target price from 675p to 750p and reiterates a buy recommendation.Informa: Westhouse Securities shifts target price from 570p to 580p and leaves its neutral rating unaltered.Intertek Group: Credit Suisse reduces target price from 3500p to 3200p downgrading to neutral.Jupiter Fund Management: Espirito Santo raises target price from 429p to 465p and leaves its buy recommendation unchanged.Legal & General Group: Goldman Sachs moves target price from 205p to 215p and maintains a neutral rating.Morrison (Wm: Societe Generale starts with a target price of 200p and a sell recommendation.Michael Page: Liberum Capital initiates with a target price of 575p and a buy recommendation.Optos: Panmure Gordon takes target price from 206p to 235p keeping a buy recommendation.Petrofac: Nomura raises target price from 1300p to 1430p upgrading to buy.Premier Oil: Deutsche Bank cuts target price from 520p to 500p and retains a buy recommendation. Societe Generale reduces target price from 385p to 320p downgrading to hold. Liberum Capital ups target price from 300p to 320p and keeps a hold recommendation. UBS cuts target price from 400p to 350p retaining a buy recommendation.Prudential: Goldman Sachs ups target price from 1500p to 1580p and keeps a strong buy recommendation.Renew Holdings: WH Ireland takes target price from 190p to 235p and reiterates its buy recommendation.Resolution: Goldman Sachs shifts target price from 335p to 340p and maintains a neutral rating.Rio Tinto: JP Morgan raises target price from 4400p to 4500p leaving its overweight rating unchanged. UBS moves target price from 4040p to 4050p and keeps a buy recommendation.Robert Walters: Liberum Capital starts with a target price of 415p and a buy recommendation.Royal Bank of Scotland: Investec moves target price from 335p to 345p, while downgrading to sell.Sainsbury: Societe Generale initiates with a target price of 370p and a hold recommendation.Smith (DS): Berenberg starts with a target price of 400p and a buy recommendation.Standard Life: Goldman Sachs ups target price from 320p to 335, but still keeps a sell recommendation.SThree: Liberum Capital initiates with a target price of 475p and a buy recommendation.St James's Place: Goldman Sachs increases target price from 770p to 810p and retains a buy recommendation. JP Morgan raises target price from 724p to 811p leaving its overweight rating unaltered.Surgical Innovations: Panmure Gordon downgrades from buy to hold with a target price of 5p.Synergy Health: Investec reduces target price from 1650p to 1400p leaving its buy recommendation unaltered.Synthomer: UBS ups target price from 255p to 280p, while downgrading from buy to neutral.Tesco: Societe Generale cuts target price from 290p to 270p keeping its sell recommendation.Tribal Group: Canaccord Genuity ups target price from 221p to 240p and stays with its buy recommendation. WH Ireland takes target price from 235p to 260p retaining a buy recommendation.Tullow Oil: Liberum Capital reduces target price from 1445p to 1367p, while its buy recommendation remains unchanged.Unilever: Panmure Gordon reduces target price from 2525p to 2280p retaining its hold recommendation.
More News
2 Dec 2020 14:24

IN BRIEF: Surgical Innovations Unit Launches Breast Reconstruction Range

IN BRIEF: Surgical Innovations Unit Launches Breast Reconstruction Range

Read more
25 Nov 2020 22:09

UK TRADING UPDATE SUMMARY: Henry Boot Picked For GBP73 Million Scheme

UK TRADING UPDATE SUMMARY: Henry Boot Picked For GBP73 Million Scheme

Read more
17 Sep 2020 15:47

IN BRIEF: Surgical Innovations Raises GBP2.2 Million From Placing

IN BRIEF: Surgical Innovations Raises GBP2.2 Million From Placing

Read more
11 Sep 2020 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Sep 2020 14:40

IN BRIEF: Surgical Innovations Interim Loss Widnes On Impairments

IN BRIEF: Surgical Innovations Interim Loss Widnes On Impairments

Read more
1 Sep 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
1 Apr 2020 07:29

Expenses And Impairment Cause Surgical Innovations' Swing To Loss

Expenses And Impairment Cause Surgical Innovations' Swing To Loss

Read more
28 Mar 2020 10:41

UK TRADING UPDATE SUMMARY: Fourth Interim Dividends Replace Finals

UK TRADING UPDATE SUMMARY: Fourth Interim Dividends Replace Finals

Read more
13 Jan 2020 10:31

Surgical Innovations Annual Profit To Meet Market Forecasts

Surgical Innovations Annual Profit To Meet Market Forecasts

Read more
11 Nov 2019 19:07

DIRECTOR DEALINGS: Surgical Innovations Non-Executive Buys Shares

DIRECTOR DEALINGS: Surgical Innovations Non-Executive Buys Shares

Read more
5 Nov 2019 18:27

DIRECTOR DEALINGS: Surgical Innovations Non-Executive Buys Shares

DIRECTOR DEALINGS: Surgical Innovations Non-Executive Buys Shares

Read more
17 Sep 2019 11:48

Surgical Innovations Cuts Guidance; Swings To Loss As Orders Slow

(Alliance News) - Surgical Innovations Group PLC on Tuesday said it swung to a loss in the first half of 2019, hit by higher expenses and lower-than-expected orders in the second quarter from the

Read more
11 Sep 2019 16:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 12 September WM Morrison SupermarketsHalf Year ResultsBrooks MacdonaldFull Year

Read more
19 Jun 2019 16:53

Surgical Innovations Finance Head Melanie Ross To Depart

(Alliance News) - Surgical Innovations PLC on Wednesday said Chief Financial Officer Melanie Ross has decided to leave the company to pursue other opportunities.Ross will leave the company

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.